867
Views
24
CrossRef citations to date
0
Altmetric
Pharmacological Aspects

Pharmacological models in Alzheimer's disease research

Modelos farmacológicos en la investigación de la enfermedad de Alzheimer

Modèles pharmacologiques dans la maladie d'Alzheimer

&
Pages 247-255 | Published online: 01 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christian Gilles, Thérèse Schunck, Gilles Erb, Izzie Jacques Namer, Yann Hodé, Jean-François Nedelec, Peter Boeijinga, Remy Luthringer & Jean-Paul Mâcher. (2002) Human models as tools in the development of psychotropic drugs. Dialogues in Clinical Neuroscience 4:4, pages 377-387.
Read now

Articles from other publishers (23)

Prachi Garodia, Mangala Hegde, Ajaikumar B. Kunnumakkara & Bharat B. Aggarwal. (2023) Curcumin, inflammation, and neurological disorders: How are they linked?. Integrative Medicine Research 12:3, pages 100968.
Crossref
Paulina Cieślik, Magdalena Borska & Joanna Monika Wierońska. (2023) A Comparative Study of the Impact of NO-Related Agents on MK-801- or Scopolamine-Induced Cognitive Impairments in the Morris Water Maze. Brain Sciences 13:3, pages 410.
Crossref
Sukriti Vishwas, Monica Gulati, Malakapogu Ravindra Babu, Ankit Awasthi, Rajan Kumar, Rubiya Khursheed, Leander Corrie, Motamarri Venkata Naga Lalitha Chaitanya, Gaurav Gupta, Hari Prasad Devkota, Dinesh Kumar Chellappan, Dileep Singh Baghel, Saurabh Singh, Kamal Dua & Sachin Kumar Singh. 2023. Deciphering Drug Targets for Alzheimer’s Disease. Deciphering Drug Targets for Alzheimer’s Disease 351 376 .
Ramkesh DalalAkanksha KulshreshthaAshish Kumar LamiyanNeelima Ram KumarPoonam Piplani. (2022) SYNERGISTIC POTENTIAL OF HONEY BEE PRODUCTS WITH RIVASTIGMINE AS NOVEL NEUROPHARMACOLOGICAL APPROACH IN RODENT MODEL OF SCOPOLAMINE-INDUCED DEMENTIA. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 82-87.
Crossref
Elena F. Shevtsova, Plamena R. Angelova, Olga A. Stelmashchuk, Noemi Esteras, Nataliia A. Vasil’eva, Andrey V. Maltsev, Pavel N. Shevtsov, Alexander V. Shaposhnikov, Vladimir P. Fisenko, Sergey O. Bachurin & Andrey Y. Abramov. (2022) Pharmacological sequestration of mitochondrial calcium uptake protects against dementia and β-amyloid neurotoxicity. Scientific Reports 12:1.
Crossref
Fernanda Cardoso Teixeira, Bruna da Silveira de Mattos, Julia Eisenhardt de Mello, Juliane Cardoso, Luiza Spohr, Karina Pereira Luduvico, Mayara Sandrielly Pereira Soares, Fabiano Barbosa Carvalho, Jessie Martins Gutierres, Anelize de Oliveira Campello Felix, Francieli Moro Stefanello & Roselia Maria Spanevello. (2021) Protective Effects of Inosine on Memory Consolidation in a Rat Model of Scopolamine-Induced Cognitive Impairment: Involvement of Cholinergic Signaling, Redox Status, and Ion Pump Activities. Neurochemical Research 47:2, pages 446-460.
Crossref
Nikolay N. Zolotov, Igor A. Schepetkin, Tatyana A. Voronina, Vladimir F. Pozdnev, Andrei I. Khlebnikov, Irina V. Krylova & Mark T. Quinn. (2021) Therapeutic Effect of Novel Cyanopyrrolidine-Based Prolyl Oligopeptidase Inhibitors in Rat Models of Amnesia. Frontiers in Chemistry 9.
Crossref
Irina Zueva, Oksana Lenina, Ramilya Kayumova, Konstantin Petrov & Patrick Masson. (2021) Protective effects of m-(tert-butyl) trifluoroacetophenone, a transition state analogue of acetylcholine, against paraoxon toxicity and memory impairments. Chemico-Biological Interactions 345, pages 109558.
Crossref
Kunal Khurana, Manish Kumar & Nitin Bansal. (2021) Lacidipine Prevents Scopolamine-Induced Memory Impairment by Reducing Brain Oxido-nitrosative Stress in Mice. Neurotoxicity Research 39:4, pages 1087-1102.
Crossref
Simran Pruthi, Karanpreet Kaur, Varinder Singh & Richa Shri. (2021) Improvement of cognitive function in mice by Citrus reticulata var. kinnow via modulation of central cholinergic system and oxidative stress. Metabolic Brain Disease 36:5, pages 901-910.
Crossref
Gabriella MacDougall, Logan Y. Brown, Boris Kantor & Ornit Chiba-Falek. (2021) The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models. Molecular Therapy 29:3, pages 949-972.
Crossref
Jan Homolak, Ana Babic Perhoc, Ana Knezovic, Jelena Osmanovic Barilar & Melita Salkovic-Petrisic. (2020) Additional methodological considerations regarding optimization of the dose of intracerebroventricular streptozotocin A response to: “Optimization of intracerebroventricular streptozotocin dose for the induction of neuroinflammation and memory impairments in rats” by Ghosh et al., Metab Brain Dis 2020 July 21. Metabolic Brain Disease 36:1, pages 97-102.
Crossref
Mehrnoosh Nikpour, Ali Sharafi, Mehrdad Hamidi & Sina Andalib. (2020) Effect of Colloidal Aqueous Solution of Fullerene (C60) in the Presence of a P-Glycoprotein Inhibitor (Verapamil) on Spatial Memory and Hippocampal Expression of Sirtuin6, SELADIN1, and AQP1 Genes in a Rat Model of Alzheimer’s Disease. ACS Chemical Neuroscience 11:17, pages 2549-2565.
Crossref
Ji Heun Jeong, Seung Eun Lee, Jeong Hoon Lee, Hyung Don Kim, Kyung-Hae Seo, Dong Hwi Kim & Seung Yun Han. (2020) Aster ageratoides Turcz. extract attenuates Alzheimer’s disease-associated cognitive deficits and vascular dementia-associated neuronal death . Anatomy & Cell Biology 53:2, pages 216-227.
Crossref
Sylvia F. Fawzi, Esther T. Menze & Mariane G. Tadros. (2020) Deferiprone ameliorates memory impairment in Scopolamine-treated rats: The impact of its iron-chelating effect on β-amyloid disposition. Behavioural Brain Research 378, pages 112314.
Crossref
Habtemariam. (2019) Natural Products in Alzheimer’s Disease Therapy: Would Old Therapeutic Approaches Fix the Broken Promise of Modern Medicines?. Molecules 24:8, pages 1519.
Crossref
Cristóbal de los Ríos & José Marco-Contelles. (2019) Tacrines for Alzheimer's disease therapy. III. The PyridoTacrines. European Journal of Medicinal Chemistry 166, pages 381-389.
Crossref
Kevin Mullane & Michael Williams. (2019) Preclinical Models of Alzheimer's Disease: Relevance and Translational Validity. Current Protocols in Pharmacology 84:1.
Crossref
Bu-Yeo Kim, Hye-Sun Lim, Yoonju Kim, Yu Jin Kim, Imhoi Koo & Soo-Jin Jeong. (2018) Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease. Molecular Neurobiology 55:12, pages 9234-9250.
Crossref
Mao Van Can, Anh Hai Tran, Dam Minh Pham, Bao Quoc Dinh, Quan Van Le, Ba Van Nguyen, Mai Thanh Thi Nguyen, Hai Xuan Nguyen, Nhan Trung Nguyen & Hisao Nishijo. (2018) Willughbeia cochinchinensis prevents scopolamine-induced deficits in memory, spatial learning, and object recognition in rodents. Journal of Ethnopharmacology 214, pages 99-105.
Crossref
Amir Erfanparast, Esmaeal Tamaddonfard & Shaghayegh Nemati. (2017) Effects of intra-hippocampal microinjection of vitamin B12 on the orofacial pain and memory impairments induced by scopolamine and orofacial pain in rats. Physiology & Behavior 170, pages 68-77.
Crossref
Surjeet Singh, Harpreet Kaur & Rajat Sandhir. (2016) Fractal dimensions: A new paradigm to assess spatial memory and learning using Morris water maze. Behavioural Brain Research 299, pages 141-146.
Crossref
Silvia Lorrio, Alejandro Romero, Laura González-Lafuente, Rocío Lajarín-Cuesta, Francisco J. Martínez-Sanz, Martín Estrada, Abdelouahid Samadi, Jose Marco-Contelles, María Isabel Rodríguez-Franco, Mercedes Villarroya, Manuela G. López & Cristóbal de los Ríos. (2013) PP2A Ligand ITH12246 Protects against Memory Impairment and Focal Cerebral Ischemia in Mice. ACS Chemical Neuroscience 4:9, pages 1267-1277.
Crossref